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Abstract
Background: Prenatal diagnosis involves methods used in early pregnancy as either screening tests or diagnostic
methods. The aims of the study were to i) investigate guidelines on prenatal diagnosis in the counties of Sweden,
ii) investigate uptake of prenatal diagnosis, and iii) background characteristics and pregnancy outcomes in relation
to different prenatal diagnostic methods.
Methods: A retrospective cross-sectional study using data from the Swedish Pregnancy Register 2011 to 2013
(284,789 pregnancies) was performed. Additionally, guidelines on prenatal diagnosis were collected. Biostatistical
and epidemiological analyses were performed including calculation of odds ratios (OR) and their 95% confidence
intervals in univariate and multivariate logistic regression analyses.
Results: The national uptake of routine ultrasound examination, Combined Ultrasound and Biochemical test (CUB),
Amniocentesis (AC) and Chorionic Villus Sampling (CVS) were 97.6, 33.0, 2.6 and 1.1%, respectively. From 2012, 6/21
counties offered CUB test to all pregnant women, nine counties at specific indications, and five counties did not
offer CUB at all. Advanced maternal age demonstrated the highest impact on uptake of prenatal diagnosis. Further,
university educational level in relation to lower educational level was associated with an increased likelihood of
undergoing CUB (OR 2.30, 95% CI 2.26–2.35), AC (OR 1.54, 95% CI 1.46–1.63) and CVS (OR 2.68, 95% CI 2.44–2.93).
Conclusion: Offers of prenatal diagnosis varied considerably between counties resulting in unequal access to
prenatal diagnosis for pregnant women. The intentions of the Swedish Health and Medical Services Act stating
equal care for all, was thus not fulfilled.
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Background
Antenatal care (ANC) is free of charge which almost all
pregnant women in Sweden attend [1]. Most pregnant
women are managed by public ANC facilities but private
ANC clinics are also available. Sweden is divided into 21
counties, including 43 maternal health care areas
(MHCAs). The 43 MHCAs issue medical guidelines
based on national recommendations, local health care
organization, and local policy related to surveillance of
pregnancy [1]. For each MHCA, an antenatal care ob-
stetrician and an antenatal care coordinator (midwife)
are responsible for the medical guidelines. ANC in
Sweden is mainly organized within the primary health
system, but exceptionally it is integrated within hospital
systems. Midwives working in ANC units are responsible
for the monitoring of pregnant women with regard to
current medical guidelines, and are responsible of refer-
ral of patients to hospital clinics when indicated. Infor-
mation on prenatal diagnosis is provided by midwives in
ANC, whereas prenatal screening or diagnostic proce-
dures are generally undertaken in hospital-based clinics.
In addition, midwives in ANC have to manage different
administrative systems related to provision of health
care, such as keeping medical records, and entering data
into the Swedish Pregnancy Register.
The Maternal Health Care Register and the Swedish
Pregnancy Register
The Swedish Maternal Health Care Register (MHCR)
is a national quality register where pregnant women
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participate on a voluntary basis by contributing with infor-
mation on their pregnancy and delivery [2]. MHCR has
collected data on outcomes of pregnancy, delivery, and
the postpartum period since 1999. The quality of data re-
corded in the MHCR has previously been investigated,
and show that most variables in the MHCR demonstrated
good to a very good degree of coverage of data, and sat-
isfying internal validity [3]. The MHCR was integrated
in the Swedish Pregnancy Register (SPR) in January 1st
2013, in a merge of three registers involved in the dif-
ferent aspects of health care during pregnancy. The
proportion of pregnancies registered in the MHCR was
81 and 85% during 2011 and 2012. The participation
rate in the SPR during 2013 was further increased,
reaching 89% of all women continuing pregnancy.
The National Board of Health and Welfare in Sweden
has issued regulations concerning counselling on different
methods of early prenatal screening and diagnostic proce-
dures [4]. These regulations state that pregnant women
and their partners must be offered this information at first
visit in ANC. Early prenatal diagnosis is defined as pre-
natal screening and diagnostic procedures during the first
22 weeks of gestation [5]. Prenatal screening or diagnostic
procedures during the first 22 weeks of gestation include
the second trimester scan usually performed at a gesta-
tional age of 18 to 20 weeks, Combined Ultrasound and
Biochemical test (CUB) and invasive tests such as either
Chorionic Villus Sampling (CVS) or Amniocentesis (AC).
CUB is a screening test, basically used to estimate the
risks of trisomy 13, 18, and 21. The CUB test is performed
during the first trimester when maternal serum samples
are collected followed by a nuchal translucency scan dur-
ing the gestational period of 11 to 13 + 6 days [6, 7]. The
combined likelihood ratios are then calculated, and when
the risk of Down’s syndrome is estimated to be higher
than 1/200 above, the woman is offered an invasive pro-
cedure in order to obtain a certain diagnosis [8]. An inva-
sive test may be a consequence of CUB, but may also be
performed due to a known or suspected genetic condition
that may be determined by DNA-PCR, CGH array or spe-
cific mutation analysis [5]. AC may be performed follow-
ing 15 completed weeks, due to the increased risk of
miscarriage or clubfoot, if the procedure is performed at
an earlier gestational age [9].
The rationale of this study was to investigate the util-
isation of prenatal diagnosis in Sweden during the study
period 2011 to 2013 in relation to the different offers of
prenatal screening and diagnostic procedures on a na-
tional level and comparing different counties.
Aims
The overall aim was to investigate background charac-
teristics and pregnancy outcomes in relation to the use
of prenatal screening methods and diagnostic procedures
in Sweden.
The specific aims of the study were to i) investigate
guidelines on prenatal diagnosis in the counties of
Sweden, ii) investigate uptake of routine ultrasound exam-
ination, combined ultrasound and biochemical test (CUB),
chorionic villus sampling (CVS) and amniocentesis (AC),
and iii) background characteristics and pregnancy out-
comes in relation to different prenatal screening and diag-
nostic procedures.
Methods
Study design and setting
This retrospective, cross-sectional, epidemiological study
analysed data on pregnancies from the Swedish Maternal
Health Care Register and the Swedish Pregnancy Register
from 2011 to 2013. MHCR was an independent register
until 2012. MHCR was integrated into the SPR, as one of
three registers when the SPR was formed in 2013. Here,
SPR refers to MHCR and SPR as one entity. Inclusion cri-
teria, for participating in the study, were being a subject
included in the SPR with a date of delivery of a live or still-
born child from January 1st 2011 to December 31st 2013,
and with a gestational age of 22 weeks and 0 days to
43 weeks and 0 days. Data on all pregnancies 2011 to
2013 were obtained from the SPR, comprising 284,789
women and their offspring. The participation rate of preg-
nant women in SPR was during 2011, 2012, and 2013, 81,
85 and 89%, respectively. The coverage of variables in rela-
tion to county, varied from 74 to 99% during 2013. Add-
itionally, medical guidelines regarding offers to pregnant
women on prenatal screening and diagnostic procedures
were collected from each Maternal Health Care Area
(MHCA; N = 43) in Sweden for 2011, 2012 and 2013. The
guidelines during this study period were almost consistent
with the exception of changes in two counties where no
pregnant women previously had been offered CUB until
2011. A new guideline was introduced during 2012 in
these two counties, offering all pregnant women CUB.
The proportion of births in these two counties corre-
sponds to 4% of all births in Sweden. Sweden includes
21 different counties where the majority of counties
host only one MHCA, whereas some larger cities host
multiple MHCAs, as for example the area of the capital
Stockholm. Results related to guidelines will be pre-
sented on county-level.
Definitions of variables
Some variables acted both as independent and dependent
variables in analyses. See the descriptions below.
Independent variables
Maternal age was defined as age in years at delivery.
Parity was defined as total number of children born
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(including the index pregnancy in the SPR). Primiparity
was defined as having delivered one child, i.e. including
the index pregnancy, and multiparity was defined as
having delivered at least 2 children (in two pregnancies
or more, including the index pregnancy). Body mass
index (BMI) was calculated with the formula BMI = kg/
m2. The different BMI groups were defined in accord-
ance with the WHO’s definition of BMI: underweight:
<18.50 kg/m2; normal weight: 18.50–24.99 kg/m2; over-
weight: 25.00–29.99 kg/m2, obesity class 1: 30.00–
34.99 kg/m2, obesity class 2: 35.00–39.99 kg/m2, and
obesity class 3: ≥40.00 kg/m2 [10]. Level of education
was defined as elementary school, high school or univer-
sity. Employment status was categorized into
“employed”, “student”, “parental leave”, “unemployed”,
“sick leave”, and “other status”. Country of origin was
categorized into Sweden, other Nordic countries
(Norway, Finland, Iceland, and Denmark) and Europe
(excluding Sweden and other Nordic countries), Africa,
Asia and other countries. The variable Alcohol screening
(Alcohol Use Disorder Identification Test = AUDIT
scores) was categorized in whether performed “yes” or
“no”. AUDIT-score ranged from 0 to 40 scores, and was
categorized into ≤5 scores and ≥6 scores, which indi-
cates harmful alcohol use [11]. Self-rated health prior to
pregnancy was categorized in “very good”, “good”, “nei-
ther good nor poor”, “poor”, and “very poor”. The fol-
lowing variables were categorized in “yes” or “no”:
smoking at 3 months prior to pregnancy, smoking at first
ANC visit, smoking at 32 weeks of gestation, use of snuff
3 months prior to pregnancy, use of snuff 3 months at
first ANC, use of snuff at 32 weeks of gestation, counsel-
ling due to fear of childbirth where fear of childbirth was
defined in the SPR as a subject being referred for coun-
selling due to fear of childbirth, treatment of psychiatric
disorder where psychiatric disorder was defined in the
SPR as either medical or psychological treatment of psy-
chiatric disorder, or both, combined ultrasound and bio-
chemical test (CUB), chorionic villus sampling (CVS)
and amniocentesis (AC).
Dependent variables
The following variables were categorized into “yes” or
“no”: combined ultrasound and biochemical test (CUB),
chorionic villus sampling (CVS), amniocentesis (AC),
counselling due to fear of childbirth and treatment of psy-
chiatric disorder. Gestational age was reported in days of
gestation and presented as a continuous variable. Mode
of delivery was categorized in “vaginal delivery”, “instru-
mental delivery” (including delivery with vacuum extrac-
tion or forceps), and “caesarean section”. Caesarean
section (CS) was further categorized in “elective caesar-
ean section” and “emergency caesarean section”. Birth
weight in grams was presented as a continuous variable.
Statistics
Categorical variables were analysed with frequencies and
percentages. Continuous variables were presented by
their mean value and standard deviation (SD), and by
their median value and interquartile range (IQR). Con-
tinuous variables were tested for the assumption of nor-
mal distribution. Test of trend was analysed by Linear-
by-Linear Association for investigation of linear trends
over the years. Test of difference between independent
groups were analysed with One-Way Anova test and in-
dependent samples t-test for parametric data, corrected
for homogeneity for variance if necessary. The Pearson’s
Chi-Square test was used for test of difference between
groups for categorical data. Level of significance was set
at p < 0.05. Odds ratios (OR) and their 95% confidence
intervals (CI) were calculated in univariate and multivar-
iable logistic regression analyses. SPSS vs. 22 and vs. 23
were used for these calculations. A Venn diagram was
created to present the uptake of CUB, CVS and AC in
the study sample. A figure presenting a map of Sweden
was created to illustrate geographical differences in up-
take of CUB, where the 21 counties were categorized
into 4 groups of CUB uptake rate: less than 10%, 10 to
29.99%, 30 to 69.99% or 70% or more.
Results
Offers on prenatal diagnosis in Sweden
All counties in Sweden except one had issued written
guidelines concerning offers of prenatal screening
methods and diagnostic procedures during the first and
second trimesters of pregnancy. These guidelines
remained unchanged in all counties except for two
counties, during the study period. Three Swedish coun-
ties offered a routine ultrasound examination at 12 weeks
of gestation for the purpose of dating and all other
counties offered a second trimester scan at the gesta-
tional age of 17–20 weeks, with the exception of one
county that accepted dating from week 16. CUB was of-
fered to all pregnant women in six counties, was offered
on indication advanced maternal age in nine counties,
and was not offered at all in five counties. The definition
of advanced maternal age as indication for CUB demon-
strated a substantial variation between counties. The dif-
ferent cut-off-values defining an indication for offering
the CUB test were: age >33 years at last menstrual
period, age ≥35 years at last menstrual period, age
≥35 years at conception, age ≥35 years at the time for
the CUB-test, and age ≥35 years at the estimated date of
delivery. In addition, one county included “anxiety re-
lated to pregnancy” as an indication for offering CUB.
All counties offered either CVS or AC as prenatal diag-
nostic procedures on the indications: maternal age
≥35 years, increased risk for chromosomal aberration
following CUB, or second trimester serum screening, or
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familial genetic condition. Three counties offered AC
only if CUB had previously been performed and indi-
cated an increased risk. During 2013, the uptake of CUB
varied between the counties from 2.2% to 80.3%,
(Table 1). Figure 1 shows a map of Sweden presenting
the 21 counties and their uptake of CUB categorized
into four levels. The lowest uptake rate, i.e. uptake less
than 10%, corresponds to counties where no pregnant
women were offered CUB. Pregnant women, living in
any of the counties where no women were offered CUB,
could still have undergone CUB but if so, privately and
at their own expense.
The study population
The study population included 284,789 pregnant women,
and the distribution of participants per year was 30.9%
(2011), 33.7% (2012) and 35.3% (2013). Background char-
acteristics for the study population are presented in
Table 2. Mean age and mean body mass index (BMI) were
30.24 years and 24.79 kg/m2, respectively. Mean age and
body mass index of primiparous and multiparous women
were 28.83 years and 31.72 years, and 24.34 kg/m2 and
25.14 kg/m2, respectively (Table 2). For multiparous
women, the variable maternal age was normally distrib-
uted 2012 and 2013 (Table 2). For primiparous women
who had undergone CUB-test the variable maternal age
was normally distributed (Table 4). All other continuous
variables demonstrated skewness to some degree. Almost
all pregnant women were examined with a routine ultra-
sound scan during pregnancy (97.6%), and the overall pro-
portions of women examined with CUB, CVS or AC were
33.0, 1.1 and 2.6% (Table 3). The percentage of women ex-
amined with CUB increased significantly during the study
period from 29.8% in 2011 to 36.2% in 2013 (p < 0.001)
(Table 3). The number of pregnant women, who were
Table 1 Uptake of Combined Ultrasound and Biochemical test
(CUB) per County (N = 21) 2011 to 2013
County CUB Proportionsa
2011 2012b 2013 2013
% % % %
1 41.0 47.4 53.2 26.1
2 18.4 19.5 21.4 17.0
3 26.4 27.8 30.1 13.8
4 81.4 78.9 80.3 4.4
5 23.7 25.0 24.9 3.5
6 64.9 66.6 66.9 3.4
7 6.7 7.9 7.0 2.9
8 59.5 61.6 63.4 2.9
9 2.4 3.0 2.7 2.7
10 5.1 5.1 3.9 2.5
11 10.4 11.7 11.0 2.5
12 6.4 9.3 9.7 2.4
13 48.9 56.3 60.9 2.4
14 1.1 1.7 2.2 2.2
15 5.3 6.7 8.8 2.1
16 13.1 13.7 12.6 2.1
17 2.9 28.8 66.7 2.1
18 4.2 18.9 75.1 1.9
19 2.0 3.9 5.3 1.3
20 13.3 16.2 15.1 1.1
21 12.5 14.6 14.2 0.5
Total 29.8 32.5 36.2 100
aProportions of births per county in relation to the total number of births in
Sweden 2013 (N = 113,593)
bCounty no 17 and no 18 changed their guidelines of prenatal diagnosis
during 2012
Fig. 1 Map of Sweden presenting the 21 counties and their uptake
of CUB categorised into four levels
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Table 2 Background characteristics and pregnancy outcomes in the Swedish Pregnancy Register 2011 to 2013 (N = 284,789)
Variable Total 2011 2012 2013 Test of differencea
N = 284,789 n = 88,140 n = 96,043 n = 100,606
n % n % n % n %
Maternal ageb, primiparous women (years)
Mean (SD)c 28.83 (5.12) 28.78 (5.17) 28.82 (5.14) 28.87 (5.07) 0.053
Min-max 13.49–56.30 13.52–52.64 13.78–56.30 13.49–52.89
Median (IQR)d 28.64 (7.07) 28.66 (7.08) 28.59 (7.05) 28.67 (7.04)
Maternal ageb, multiparous women (years)
Mean (SD)c 31.72 (4.90) 32.29 (4.89) 32.21 (4.90) 32.16 (4.89) <0.001
Min-max 15.00–57.00 17.07–53.25 16.41–54.47 15.67–57.34
Median (IQR)d 32.30 (6.88) 32.41 (6.91) 32.28 (6.84) 32.23 (6.89)
Maternal ageb in age-groups (years)
< 20 3976 1.4 1369 1.6 1319 1.4 1288 1.3
20–24 38,832 13.6 11,990 13.6 13,222 13.8 13,611 13.5
25–29 84,129 29.5 25,578 29.0 28,393 29.6 30,158 30.0
30–34 95,772 33.6 29,463 33.4 32,243 33.6 34,066 33.9
35–39 50,717 17.8 16,215 18.4 17,010 17.7 17,492 17.4
40–44 10,705 3.8 3323 3.8 3625 3.8 3757 3.7
> 44 583 0.2 167 0.2 213 0.2 203 0.2
Body mass index (kg/m2)
Mean (SD)c 24.79 (4.65) 24.75 (4.62) 24.82 (4.67) 24.81 (4.66) 0.002
Min-max 13.03–71.63 13.82–62.06 13.63–67.22 13.03–71.63
Median (IQR)d 23.80 (5.00) 23.74 (5.41) 23.81 (5.45) 23.81 (5.52)
< 18.5 6838 2.5 2044 2.4 2328 2.5 2466 2.5
18.5–24.99 163,856 59.2 50,787 59.7 55,203 58.9 57,866 58.9
25–29.99 70,440 25.4 21,478 25.3 23,870 25.5 25,092 25.5
30–34.99 25,166 9.1 7526 8.8 8573 9.2 9067 9.2
35.39.99 7899 2.9 2374 2.8 2734 2.9 2791 2.8
≥ 40 2759 1.0 836 1.0 969 1.0 954 1.0
Educational level
Elementary school 20,860 8.7 6662 9.4 6870 8.5 7328 8.4 <0.001
High school 95,564 40.0 27,821 39.4 32,660 40.3 35,083 40.1
University 122,623 51.3 36,155 51.2 41,432 51.2 45,036 51.5
Main occupation
Employed 195,880 70.3 59,890 70.3 66,622 70.5 69,368 70.1 <0.001
Student 31,021 11.1 9697 11.4 10,364 11.0 10,960 11.1
Parental leave 20,469 7.3 6082 7.1 6911 7.3 7475 7.5
Unemployed 15,163 5.4 4955 5.8 4996 5.3 5212 5.3
Sick leave 4421 1.6 1241 1.5 1557 1.6 1623 1.6
Other 11,686 4.2 3300 3.9 4013 4.2 4373 4.4
Country of birth
Sweden 221,398 79.4 70,376 81.8 74,187 78.9 76,835 77.8 <0.001
Other Nordic countriese 2374 0.8 613 0.8 832 0.8 929 0.8
Europef 12,861 4.6 3486 4.0 4481 4.8 4900 5.0
Africa 10,782 3.9 2780 3.2 3658 3.9 4344 4.4
Asia 25,597 9.2 6886 8.0 8976 9.5 9735 9.9
Other 5902 2.1 1917 2.2 1940 2.1 2045 2.1
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Table 2 Background characteristics and pregnancy outcomes in the Swedish Pregnancy Register 2011 to 2013 (N = 284,789)
(Continued)
Smoking 3 months prior to pregnancy 38,854 13.8 12,134 13.9 13,285 14.0 13,435 13.5 0.004
Smoking at first ANCg visit 15,874 5.6 5062 5.8 5475 5.7 5337 5.4 <0.001
Smoking at 32 weeks of gestation 11,990 4.2 3923 4.5 4133 4.3 3934 3.9 <0.001
Use of snuff 3 months prior to pregnancy 9954 3.5 2530 2.9 3506 3.7 3918 3.9 <0.001
Use of snuff at first ANCg visit 2858 1.0 793 0.9 945 1.0 1120 1.1 <0.001
Use of snuff at 32 weeks of gestation 1721 0.6 548 0.6 561 0.6 612 0.6 0.572
Alcohol screening (AUDIT)h 245,544 88.1 74,712 86.7 81,408 86.7 89,424 90.6 <0.001
AUDIT-scorej
Mean (SD)c 2.19 (2.19) 2.28 (2.22) 2.20 (2.22) 2.09 (2.15)
Min-max 0–40 0–39 0–40 0–40
Median (IQR)d 2.00 (2) 2.00 (2) 2.00 (2) 2.00 (3)
≤ 5p 229,854 94.0 69,110 93.6 76,327 93.8 84,417 94.4 <0.001
≥ 6p 14,751 6.0 4704 6.4 5044 6.2 5003 5.6
Self-rated health prior to pregnancy 241,854 84.9 70,633 80.1 82,594 86.0 88,627 88.1
Very good 72,321 29.9 19,838 28.1 24,472 29.6 28,011 31.6 <0.001
Good 141,251 58.4 41,299 58.5 48,441 58.6 51,511 58.1
Neither good nor poor 20,425 8.4 6793 9.6 6962 8.4 6670 7.5
Poor 6325 2.6 2174 3.1 2197 2.7 1954 2.2
Very poor 1532 0.6 529 0.7 522 0.6 481 0.5
Counselling due to fear of childbirth 21,595 7.6 6518 7.5 7186 7.5 7891 7.9 0.001
Treatment of psychiatric disorder 17,724 6.3 5122 5.9 6061 6.4 6541 6.5 <0.001
Gestational age (days)
Mean (SD)c 278.0 (13.8) 278.0 (13.9) 277.8 (13.9) 278.1 (13.7) <0.001
Min-max 154–301 155–301 154–301 154–301
Median (IQR)d 280.00 (13.00) 280.00 (13.00) 280.00 (13.00) 280.00 (13.00)
Mode of delivery 283,660 99.6 87,915 99.7 95,594 99.5 100,151 99.5
Vaginal 217,898 76.8 67,277 76.5 73,333 76.7 77,288 77.2 <0.001
Instrumental 19,177 6.8 6208 7.1 6616 6.9 6353 6.3
Caesarean section 46,585 16.4 14,430 16.4 15,645 16.4 16,510 16.5
Caesarean section (CS)
Elective CSj 20,272 43.6 6321 43.9 6718 43.0 7233 43.9 0.193
Emergency CSj 26,214 56.4 8085 56.1 8897 57.0 9232 56.1
Birth weight (grams)k
Mean (SD)c 3542 (556) 3540 (557) 3543 (556) 3543 (556) 0.352
Min-max 300–6640 300–6050 305–6270 300–6640
Median (IQR)d 3550 (670) 3550 (675) 3550 (674) 3550 (670)
aTest of difference between years using One-Way Anova test on numeric variables, and Pearsons’s Chi-Square test for categorical variables
bMaternal age at delivery
cSD = Standard Deviation
dIQR = Interquartile Range
eOther Nordic countries includes Norway, Finland, Iceland and Denmark
fThe Nordic countries are excluded
gAntenatal care
hAssessment of use of alcohol prior to pregnancy with screening instrument Alcohol Use Disorder Identification Test (AUDIT)
i AUDIT score ranging from 0 to 40
jCaesarean section
kSingletons exclusively included in analysis
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examined with CUB, CVS or AC, or any combinations of
these procedures, was in total 98,697, which corresponds
to 33.4% of all women and is presented in a Venn diagram
(Fig. 2). Of all pregnant women who were examined with
CUB, 1.1% (n = 1252) thereafter underwent CVS, and
2.7% (n = 2493) underwent AC after CUB. Of all women
who were examined with CVS (n = 2970), 42.2% had
undergone CUB prior to CVS. Of all women who were
examined with AC (n = 7279), 34.2% had undergone CUB
prior to AC.
Mean age for primiparous women who underwent
CUB, CVS or AC was 31.34, 33.79 and 33.65 years, re-
spectively (Table 4). Overall mean age for pregnant
women who had not been examined with CUB, CVS or
AC was 28.84 (defined as “all others” in Table 4), where
the mean age for primiparous and multiparous women in
this category was 27.09 and 30.29 years, respectively. BMI
for pregnant women who had undergone CUB, CVS or
AC was 24.40, 24.10 and 24.94, respectively, whereas BMI
for pregnant women who had not undergone CUB, CVS
or AC (“all others”) was 24.99. There was a statistically
significant difference in BMI between those who under-
went CUB and “all others” (p-value <0.001) (Table 4).
Pregnant women who underwent CUB, CVS or AC re-
ported being employed in significantly higher proportions
(80.3, 87.0 and 77.8%, respectively), vs. 65% for women who
had not undergone CUB, CVS or AC (p-value <0.001).
Information on country of birth was available for al-
most all participants (Table 2). Sweden as country of
birth was reported by 79.4% of all pregnant women
(Table 2). Pregnant women who had undergone CUB,
CVS and AC, reported Sweden as country of birth in
84.5, 85.4 and 81.8% of the cases, respectively. The cor-
responding figure for pregnant women who had not
been exposed to CUB, CVS or AC was 76.7%. That
means that a significantly lower proportion of women
who were born outside of Sweden was examined by
CUB, CVS and AC (p-value <0.001) (Table 4).
A proportion of 35.2% of women with a Nordic origin
were exposed to CUB. The corresponding figures for
women born in Europe, Africa, and Asia were 31.5, 11.8
and 24.5% respectively. Smoking was reported to a signifi-
cantly lower degree (p-value <0.001) at all three check
points, i.e. 3 months prior to pregnancy, at first antenatal
visit and at gestational age of 32 weeks, by women who
had undergone CUB compared to those who had not been
examined by CUB, CVS or AC, i.e. “all others” (Table 4).
Table 3 Uptake of routine ultrasound examination, Combined Ultrasound and Biochemical test (CUB), Chorionic Villus Sampling
(CVS) and Amniocentesis (AC) during 2011 to 2013, and test of trenda
Variable Total 2011 2012 2013 Trenda
N = 284,789 n = 88,140 n = 96,043 n = 100,606
n % n % n % n %
Ultrasound 281,562 98.9 85,561 97.1 97,500 99.6 100,310 99.7
Yes 274,899 97.6 83,549 97.6 93,386 97.6 97,964 97.7 0.716
No 6663 2.4 2.012 2.4 2314 2.4 2337 2.3
CUB 278,230 98.0 84,827 96.2 94,900 98.8 99,503 98.9
Yes 92,207 33.0 25,316 29.8 30,826 32.5 36,065 36.2 <0.001
No 187,023 67.0 59,511 70.2 64,074 67.5 63,438 63.8
CVS 280,898 98.6 85,308 96.8 95,465 99.4 100,125 99.5
Yes 2983 1.1 868 1.0 927 1.0 1188 1.2 <0.001
No 277,915 98.9 84,440 99.0 94,538 98.8 98,937 98.8
AC 280,667 98.6 85,213 99.3 95,395 99.3 100,059 99.5
Yes 7318 2.6 2500 2.9 2473 2.6 2345 2.3 <0.001
No 273,349 97.4 82,713 97.1 92,922 97.4 97,714 97.7
aTest of trend by Linear-by-Linear Association
Fig. 2 Pregnant women that were examined with CUB, AC and CVS
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Table 4 Background characteristics and pregnancy outcomes in relation to prenatal screening or diagnostic procedures in the
Swedish Pregnancy Register 2011 to 2013 (N = 284,789)
Variable CUBa CVSb ACc All othersd Test of differencee
n = 92,207 n = 2983 n = 7318 n = 186,092
n % n % n % n %
Maternal agef, primiparous women (years)
Mean (SD)g 31.34 (5.17) 33.79 (5.74) 33.65 (6.11) 27.09 (4.58) <0.001
Min-max 15.09–56.30 17.29–49.03 16.74–49.83 13–54
Median (IQR)h 31.34 (7.32) 34.41 (8.38) 34.92 (9.15) 27.51 (6.41)
Maternal agef, multiparous women (years)
Mean (SD)g 34.45 (4.45) 36.87 (4.65) 37.13 (4.66) 30.29 (4.52) <0.001
Min-max 16.41–55.34 19.10–51.76 16.41–48.68 15–57
Median (IQR)h 34.97 (5.72) 37.58 (5.66) 37.82 (5.45) 30.87 (6.07)
Maternal agef in age-groups (years)
< 20 388 0.4 8 0.3 23 0.3 3566 1.9
20–24 5863 6.4 99 3.3 313 4.3 32,702 17.6
25–29 17,617 19.1 300 10.1 733 10.0 65,926 35.4
30–34 31,792 34.5 649 21.8 1314 18.0 62,944 33.8
35–39 30,179 32.7 1262 42.3 3148 43.0 17,676 9.5
40–44 6093 6.6 628 21.1 1675 22.9 2991 1.6
> 44 270 0.3 36 1.2 109 1.5 211 0.1
Body mass index (kg/m2)
Mean (SD)g 24.40 (4.34) 24.10 (4.10) 24.94 (4.52) 24.99 (4.80) <0.001
Min-max 13.82–56.65 15.24–51.31 15.24–50.69 13.03–71.63
Median (IQR)h 23.45 (5.0) 23.18 (5.0) 24.01 (5.0) 23.95 (6.0)
< 18.5 1965 2.2 52 1.8 121 1.7 4766 2.6
18.5–24.99 56,723 63.2 1918 66.3 4140 58.2 103,359 57.2
25–29.99 21,639 24.1 663 22.9 1926 27.1 47,160 26.1
30–34.99 6863 7.6 195 6.7 652 9.2 17,741 9.8
35.39.99 1992 2.2 48 1.7 203 2.9 5744 3.2
≥ 40 629 0.7 18 0.6 68 1.0 2071 1.1
Educational level
Elementary school 3242 4.1 69 2.7 334 5.3 17,353 11.2 <0.001
High school 24,324 31.1 608 23.7 2078 33.1 69,523 44.8
University 50,763 64.8 1887 73.6 3869 61.6 68,302 44.0
Main occupation
Employed 72,519 80.3 2439 83.7 5582 77.8 118,371 65.0 <0.001
Student 6467 7.2 146 5.0 524 7.3 24,121 13.3
Parental leave 5059 5.6 149 5.1 459 6.4 15,002 8.2
Unemployed 3320 3.7 78 2.7 294 4.1 11,601 6.4
Sick leave 1306 1.4 36 1.2 119 1.7 3009 1.7
Other 1610 1.8 66 2.3 194 2.7 9897 5.4
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Table 4 Background characteristics and pregnancy outcomes in relation to prenatal screening or diagnostic procedures in the
Swedish Pregnancy Register 2011 to 2013 (N = 284,789) (Continued)
Country of birth
Sweden 76,276 84.5 2482 85.4 5876 81.8 139,881 76.7 <0.001
Other Nordic countriesi 904 1.0 31 1.1 74 1.0 1406 0.8
Europej 3971 4.4 102 3.5 332 4.6 8617 4.7
Africa 1243 1.4 37 1.3 127 1.8 9438 5.2
Asia 6132 6.8 196 6.7 590 8.2 18,955 10.4
Other 1727 1.9 57 2.0 180 2.5 4007 2.2
Smoking 3 months prior to pregnancy 9583 10.5 229 7.7 751 10.3 28,659 15.6 <0.001
Smoking at first ANCk visit 3445 3.8 76 2.6 347 4.8 12,144 6.6 <0.001
Smoking at 32 weeks of gestation 2527 2.8 48 1.6 289 4.0 9238 5.0 <0.001
Use of snuff 3 month prior to pregnancy 2493 2.7 64 2.2 213 2.9 7268 3.9 <0.001
Use of snuff at first ANC visit 646 0.7 22 0.7 85 1.2 2134 1.2 <0.001
Use of snuff at 32 weeks of gestation 385 0.4 13 0.4 41 0.6 1303 0.7 <0.001
Alcohol screening (AUDIT)l 81,686 90.3 2568 88.4 6313 86.3 158,335 87.0 <0.001
AUDIT-scorem
Mean (SD) 2.34 (1.96 2.26 (1.74) 2.12 (1.90 2.11 (2.32)
Min-max 0–38 0–18 0–29 0–40
Median (IQR)h 2.00 (2) 2.00 (2) 2.00 (2) 2.00 (3)
≤ 5p 76,786 94.5 2462 96.3 6012 95.7 82,067 94.6 <0.001
≥ 6p 4485 5.5 95 3.7 270 4.3 4703 5.4
Self-rated health prior to pregnancy
Very good 25,990 33.0 834 32.5 1887 30.5 44,643 28.3 <0.001
Good 44,563 56.6 1433 55.9 3489 56.5 93,611 59.4
Neither good nor poor 5877 7.5 217 8.5 583 9.4 14,047 8.9
Poor 1817 2.3 64 2.5 187 3.0 4334 2.7
Very poor 440 0.6 15 0.6 34 0.6 1056 0.7
Counselling due to fear of childbirth 8900 9.7 324 10.9 745 10.2 12,023 6.5 <0.001
Treatment of psychiatric disorder 6002 6.5 185 6.3 533 7.3 11,275 6.1 <0.001
Gestational age (days)
Mean (SD)g 278.0 (13.7) 276.6 (15.0) 276.5 (15.4) 278.0 (13.8) 0.326
Min-max 154–301 158–300 157–301 154–301
Median (IQR)h 280.0 (13.0) 279.0 (13.0) 279 (15.0) 280 (13.00)
Mode of delivery
Vaginal 6885 73.9 2079 70.2 5133 70.3 145,486 78.5 <0.001
Instrumental 6376 6.9 163 5.5 392 5.4 12,468 6.7
Caesarean section 17,574 19.1 721 24.3 1772 24.3 27,405 14.8
Caesarean section (CS) n
Elective CSn 8650 49.3 297 58.7 916 51.7 10,700 39.1 <0.001
Emergency CSn 8893 50.7 422 41.3 855 48.3 16,639 60.9
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Women who had been examined by CUB, CVS or AC
reported having received counselling due to fear of child-
birth in 9.7, 10.9 and 10.2% of cases, respectively. Women
who had not been examined with CUB, CVS or AC re-
ported having received counselling due to fear of child-
birth in a significantly lower proportion (6.5%; p-value
<0.001) (Table 4). There was no significantly difference be-
tween the group of women who had undergone CUB and
women included in the group “all others” regarding gesta-
tional age at delivery (Table 4).
The overall proportion of CS in the study group
was 16.4% (Table 2). For pregnant women who had
undergone CUB, CVS and AC, the prevalence of CS
were 19.1, 24.3 and 24.3%, respectively, and the corre-
sponding figure for “all others” was significantly lower
14.8% (p-value <0.001) (Table 4).
If caesarean section had been performed, the propor-
tions of those who underwent elective CS or emergency
CS were as follows; women who had undergone CUB,
49.3% and 50.7%, women who had undergone AC, 51.7%
and 48.3% and women who had undergone CVS, 58.7%
and 41.3% respectively. The corresponding figures for
women included in the group “all others” were 39.1%
(elective CS) and 60.9% (emergency CS), (Table 4).
The odds ratio for undergoing CUB at a maternal age
of 35 years or older, was highly increased (4.36; 95% CI
4.28–4.45). When the OR was adjusted for educational
level the OR still remained increased (4.00; 95% CI
3.91–4.08). Table 5 presents univariate and multivari-
able logistic regression analyses for the uptake of CUB
in relation to specific background characteristics. Edu-
cational level demonstrated a strong impact on the like-
lihood of being examined with a CUB test. Women
under the age of 35 years, having attended university,
had an Adjusted Odds Ratio (AOR) of 1.79 (95% Ad-
justed Confidence Interval (ACI) 1.75–1.83) for under-
going CUB (Table 5). The corresponding figure for
women 35 years or older who had attended university
was AOR 1.53 (95% ACI 1.47–1.61) (Table 5). Pregnant
women with a BMI of 25 or more, women who were
unemployed, women who were born outside of Sweden
and women who reported ongoing smoking at their
first visit at ANC demonstrated a decreased AOR for
undergoing CUB (Table 5). Women under the age of
35 years who had received counselling due to fear of
childbirth had an increased AOR of 1.38 (95% ACI
1.32–1.45) for undergoing CUB, whereas the corre-
sponding figure for women 35 years or older was some-
what lower (1.27; 95% ACI 1.18–1.28). Women in both
age groups, having received treatment for psychiatric
disorder, demonstrated a small but statistically signifi-
cant increased AOR for undergoing CUB (Table 5).
Maternal age demonstrated the highest impact on the
likelihood of undergoing invasive prenatal diagnosis
(AC: COR 7.97; 95% CI 7.58–8.38, and CVS: COR 6.72;
95% CI 6.23–7.24). Further, women who had achieved
an educational level corresponding to university had an
increased likelihood of undergoing AC (COR 1.54; 95%
CI 1.46–1.62) and CVS (2.68; 95% CI 2.45–2.92), in rela-
tion to women with a lower educational level. Their in-
creased odds ratios for AC and CVS remained
unchanged after adjusting for maternal age (AC: AOR
1.54; 95% ACI 1.46–1.62, and CVS: AOR 2.68; 95% ACI
2.45–2.92). Additionally, pregnant women who had re-
ceived counselling due to fear of childbirth demon-
strated a higher likelihood of undergoing AC or CVS
(AC: COR 1.39; 95% CI 1.29–1.50, and CVS: COR 1.49;
95% CI 1.32–1.67), in comparison to those who had not
Table 4 Background characteristics and pregnancy outcomes in relation to prenatal screening or diagnostic procedures in the
Swedish Pregnancy Register 2011 to 2013 (N = 284,789) (Continued)
Birth weight (grams)o
Mean (SD)g 3549 (552) 3531 (585) 3510 (620) 3539 (557) 0.001
Min-max 310–6270 400–5710 370–5776 300–6640
Median (IQR)h 3560 (665) 3555 (686) 3548 (706) 3545 (680)
aCUB = Combined Ultrasound and Biochemical test
bCVS = Chorionic Villus Sampling
cAC = Amniocentesis
dAll others = Pregnant women who did not undergo any of the prenatal diagnostic procedures CUB, CVS or AC
eTest of difference between the two groups; pregnant women who underwent CUB and “all others” using t-test for continuous variables and Pearson’s Chi-Square
test for categorical variables
fMaternal age at delivery
gSD = Standard Deviation
hIQR = Interquartile Range
i Other Nordic countries includes Norway, Finland, Iceland and Denmark
j The Nordic countries excluded
kAntenatal care
l Assessment of use of alcohol prior to pregnancy with screening instrument Alcohol Use Disorder Identification Test (AUDIT)
mAUDIT score range from 0 to 40
nCaesarean section
oSingletons exclusively included in analysis
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been counselled for fear of childbirth. When adjusted for
age and educational level the likelihood remained signifi-
cantly increased for AC (AOR 1.14; 95% ACI 1.04–1.24)
and CVS (AOR 1.15; 95% ACI 1.01–1.31).
A decreased likelihood of undergoing AC or CVS was
demonstrated for pregnant women who reported coun-
try of birth outside of Sweden, compared to those who
were born in Sweden (AC: COR 0.85; 95% CI 0.80–0.91,
and CVS: COR 0.66; 95% CI 0.59–0.73). When adjusted
for age and educational level the odds ratios remained
significantly decreased (AC: AOR 0.88; 95% ACI 0.82–
0.95, and CVS: AOR 0.81; 95% ACI 0.72–0.91).
Discussion
The aim of this study was to make a national survey on
guidelines concerning offers on prenatal diagnosis in
Sweden. Further, we aimed to investigate background
characteristics and pregnancy outcomes in relation to
the uptake of different prenatal diagnostic methods.
During the study period of 2011 to 2013 in Sweden
there was an absence of a national consensus regarding
guidelines on offers of prenatal diagnosis. The Swedish
law states that all pregnant women should be offered in-
formation on prenatal diagnosis [4]. However, the oppor-
tunities of undergoing different prenatal screening or
diagnostic procedures were not equally distributed dur-
ing the time period under study among Swedish coun-
ties. On a national level, the uptake of the second
trimester scan, CVS and AC was relatively stable during
the study period whereas the uptake of CUB increased
from 29.8%, 2011 to 36.2% in 2013. A Danish study per-
formed 2008, shows a sharp decline in the uptake of in-
vasive prenatal diagnosis when implementing screening
programs offering CUB [12]. A study exploring determi-
nants of participating in the first trimester combined test
shows that advanced maternal age is the primary indica-
tion and has the highest impact for uptake of CUB [13].
As expected, our study displayed increased maternal age
as the factor with the highest impact on whether preg-
nant women were examined with a CUB test. Further,
Table 5 Univariate and multivariable logistic regression analysis for undergoing Combined Ultrasound and Biochemical test (CUB) in
relation to maternal age divided into two age groups and to specified background characteristics
Maternal age <35 years Maternal age ≥35 years
Variable Crude OR CI 95% Adjusted OR a Adjusted CI 95% Crude OR CI 95% Adjusted ORa Adjusted CI 95%
Educational level
Elementary school, high school 1 1 1 1
University level 2.03 1.98–2.07 1.79 1.75–1.83 1.86 1.79–1.93 1.53 1.47–1.61
Body mass index (kg/m2)
< 25 1 1 1 1
≥ 25 0.75 0.73–0.76 0.84 0.82–0.86 0.65 0.63–0.68 0.76 0.73–0.80
Main occupation
Employed, student, parental leave 1 1 1 1
Unemployed, sick leave, other 0.51 0.49–0.53 0.70 0.67–0.74 0.46 0.44–0.49 0.64 0.59–0.70
Country of birth
Sweden 1 1 1 1
Other 0.60 0.58–0.61 0.76 0.74–0.79 0.55 0.53–0.57 0.74 0.70–0.78
Smoking at first visit at antenatal care
No 1 1 1 1
Yes 0.62 0.59–0.65 0.87 0.82–0.92 0.59 0.54–0.64 0.74 0.66–0.84
Self-rated health prior to pregnancy
Very good and good 1 1 1 1
Poor and very poor 0.85 0.74–0.98 0.96 0.82–1.13 0.62 0.50–0.76 0.80 0.63–1.02
Counseling due to fear of childbirth
No 1 1 1 1
Yes 1.41 1.36–1.46 1.38 1.32–1.45 1.40 1.32–1.48 1.27 1.18–1.28
Treatment of psychiatric disorder
No 1 1 1 1
Yes 1.03 0.99–1.08 1.15 1.09–1.22 1.04 0.98–1.11 1.16 1.05–1.28
aAdjusted for all other variables included in the analysis
Petersson et al. BMC Pregnancy and Childbirth  (2016) 16:365 Page 11 of 13
educational level and country of birth were also signifi-
cant background factors for women’s utilization of CUB.
A study investigating effects of knowledge, education
and experience of first trimester screening shows that
women with a university education have a higher degree
of knowledge of first trimester screening [14]. A Swedish
study from 2012, exploring the effects of a public video
aiming for an informed choice in relation to exposure to
second trimester ultrasound, shows that women with
college or university educational level were more likely
to make an informed choice [15]. In our study women
who had achieved a university education were more
likely to undergo the CUB test, and the effect of educa-
tional level was more pronounced for women younger
than 35 years of age in comparison to women 35 years
or older. It is likely that higher education implicates a
higher ability to gain, interpret and use information on
different health offers, health promotion or risk factors.
Ethnicity in relation to uptake of prenatal diagnosis has
been investigated in several previous studies [16–18]. A
register-based study in the Netherlands shows that
women with a North-African ethnic origin have the low-
est participation rate in prenatal screening for Down’s
syndrome, only 8% participation rate compared to the
higher rate for women with a Dutch (28%) or other
Western origin (33%) [16]. Also, an Australian study dem-
onstrates that ethnicity is strongly associated with the up-
take of prenatal diagnosis [17]. Women with Caucasian
ethnicity were more likely to utilize prenatal diagnosis
than other women. The proportion of screening was sig-
nificantly lower for women of aboriginal origin [17]. It has
been reported that Asian women living in the United
Kingdom are less likely than white women to be offered
and undergo screening for Down’s syndrome [18]. Our
study showed that women, 35 years or older and with a
country of birth outside of Sweden presented a 45% de-
creased likelihood of undergoing CUB. The lowest uptake
was demonstrated by women born in Africa. Lower up-
take of prenatal diagnosis in minority ethnic groups and
among socioeconomically disadvantaged women, has been
shown to reflect lower rates of informed choice rather
than more negative attitudes towards screening [19]. Our
study was not able to investigate possible effects of lan-
guage barriers for pregnant women with no or little skills
in Swedish to make an informed choice. In our study,
country of birth had a somewhat higher impact on
utilization of CUB than on utilization of CVS or AC. This
might be explained by the difficulty to inform about risk
evaluation and by providing pregnant women with correct
information thus facilitating for making an informed
choice. Pregnant women who had received counselling
due to fear of childbirth utilized prenatal diagnosis to a
higher degree than other women. To our knowledge, asso-
ciation between fear of childbirth and utilization of
prenatal diagnosis has not previously been investigated. It
seems likely that a higher level of anxiety could be mani-
fested both as fear of childbirth as well as an increased
concern related to the pregnancy resulting in increased
number of medical procedures.
During the study period, the SPR did not include data on
Non-Invasive Prenatal testing (NIPT). This method is based
on analysis of cell-free fetal DNA in maternal blood [20]. In
Sweden, NIPT is currently offered only in a few counties
and strictly on specific indications. However, this method is
accessible on the pregnant woman’s own expense.
Methodological considerations
During the study period, the Swedish Pregnancy Register
demonstrated a satisfactory coverage of pregnancies and
moreover, all counties of Sweden are represented in the
SPR. Data in the Swedish Medical Birth Register for
2012, demonstrate a mean maternal age, for primiparous
women, of 28.4 years, and a mean BMI (all pregnant
women) of 24.8 [21], and the corresponding figures in
the SPR 2012, were 28.8 (years) and 24.8 (BMI), respect-
ively. These results indicate that data in SPR are very
similar to data in the Swedish Medical Register that is a
compulsory health register demonstrating an almost
complete coverage of pregnant women in Sweden. The
validity of data in the SPR has previously been investi-
gated and most variables demonstrate good internal val-
idity and coverage [3]. However, the validity check also
revealed that the absolute numbers of invasive prenatal
diagnosis such as CVS and AC are underestimated [3].
The SPR does not include information on pregnancies
with a gestational age of less than 23 weeks of gestation.
Therefore, an additional limitation of this study was that
different frequencies of prenatal diagnosis could not be
established for this category of pregnant women that
may have terminated their pregnancies.
Conclusions
Offers of prenatal diagnostic procedures varied consider-
ably between counties in Sweden. Maternal age, as ex-
pected, demonstrated the strongest association with the
uptake of CUB, AC and CVS. Further, educational level
was a strong predictor of uptake of prenatal diagnosis.
These circumstances result in an unequal access of pre-
natal diagnostic tests for pregnant women. The inten-
tions of the Swedish Health and Medical Services Act
stating that equal care should be provided for all, was
thus not fulfilled. Expecting couples should be offered
the same opportunities on prenatal diagnosis nationally.
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